NCT05315947View on ClinicalTrials.gov

A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Male Japanese Study Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

May 13, 2022

Study Completion Date

May 13, 2022

Conditions
Healthy Study Participants
Interventions
DRUG

brivaracetam

Study participants will receive a single-dose of brivaractam tablet (reference - Treatment A) administered orally.

DRUG

brivaracetam

Study participants will receive a single-dose of brivaractam dry syrup (test - Treatment B) administered orally.

Trial Locations (1)

Unknown

EP0110 1, Sumida-ku

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY